Literature DB >> 12552434

Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?

Danuta M Skowronski1, Hang Lu, Richard Warrington, Richard G Hegele, Gaston De Serres, Kent HayGlass, Donald Stark, Rick White, Jane Macnabb, Yan Li, Heather E Manson, Robert C Brunham.   

Abstract

During the 2000-2001 season in Canada, a newly identified oculorespiratory syndrome (ORS) was observed in patients after immunization with inactivated influenza vaccine. ORS was associated with a high proportion of microaggregates of unsplit virions in the implicated vaccine and had clinical features suggesting delayed-onset hypersensitivity. We explore the association between in vitro cytokine balance (type 1 vs. type 2) and clinical ORS after influenza vaccination. We report the balance of interferon (IFN)-gamma, interleukin (IL)-10, IL-5, and IL-13 expression by peripheral blood mononuclear cells (PBMC) among unvaccinated, vaccinated ORS-affected, and vaccinated ORS-unaffected persons after in vitro challenge with implicated and nonimplicated vaccines. Antigen-stimulated PBMC from vaccinated persons produced significantly more IFN-gamma than did those from unvaccinated persons. There was a statistically significant type 2 polarization among unvaccinated compared with vaccinated persons. Although vaccinated ORS-affected individuals had less of a type 1 basis than did vaccinated unaffected individuals, this difference was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552434     DOI: 10.1086/368117

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.

Authors:  Mona Al-Dabbagh; Keswadee Lapphra; David W Scheifele; Scott A Halperin; Joanne M Langley; Patricia Cho; Tobias R Kollmann; Yan Li; Gaston De Serres; Edgardo S Fortuno; Julie A Bettinger
Journal:  Clin Vaccine Immunol       Date:  2013-05-22

Review 2.  Immunogenicity of therapeutic proteins: influence of aggregation.

Authors:  Kirsty D Ratanji; Jeremy P Derrick; Rebecca J Dearman; Ian Kimber
Journal:  J Immunotoxicol       Date:  2013-08-06       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.